skip banner navigation
National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
NCI Cancer Bulletin
  Subscribe Now
To begin your subscription to the NCI Cancer Bulletin, enter your e-mail address below:




  Send to a Colleague
Do you know someone who would enjoy receiving the NCI Cancer Bulletin?

Send to (e-mail address):



Your e-mail address:



Your name:




Quick Links
Dictionary

Funding Opportunities

NCI Publications

NCI Calendar

Español
Need Help?

Inside This Week's Issue

Dear Colleagues:

I am pleased to present this week's NCI Cancer Bulletin. Our lead story describes the Progress for Patients Award Program, a partnership between NCI and the Avon Foundation that is providing more than $7 million to support breast cancer research this year. The Director's Update by NCI Deputy Director Dr. Karen Antman discusses the importance of NCI's translational research initiatives. Other articles of interest include:

  • A spotlight on NCI's recent grant to support nanotechnology research at Emory University and other institutions in Georgia
  • A research study on breast density and mammography sensitivity
  • A study on a drug combination that improves outcomes in advanced prostate cancer
  • A clinical trial using immunotherapy to treat metastatic melanoma

I hope you will find this issue of the NCI Cancer Bulletin interesting and informative.

Sincerely,

Andrew C. von Eschenbach, M.D.
Director, National Cancer Institute


NCI Cancer Bulletin PDF

     Download Current Issue

     View Previous Issues





Send Us Your Feedback  Enter your comments below:




Back to TopBack to Top

skip footer navigation

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health FirstGov.gov